verapamil has been researched along with Cavernitis, Fibrous in 68 studies
Verapamil: A calcium channel blocker that is a class IV anti-arrhythmia agent.
verapamil : A racemate comprising equimolar amounts of dexverapamil and (S)-verapamil. An L-type calcium channel blocker of the phenylalkylamine class, it is used (particularly as the hydrochloride salt) in the treatment of hypertension, angina pectoris and cardiac arrhythmia, and as a preventive medication for migraine.
2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile : A tertiary amino compound that is 3,4-dimethoxyphenylethylamine in which the hydrogens attached to the nitrogen are replaced by a methyl group and a 4-cyano-4-(3,4-dimethoxyphenyl)-5-methylhexyl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Verapamil and dexamethasone iontophoresis is a safe and reliable treatment resolving painful erections in the acute phase of PD." | 3.78 | Transdermal iontophoresis with verapamil and dexamethasone in the acute phase of peyronie's disease. Our experience. ( Coloma, A; Fernández Arjona, M; Formoso, T; Garrido Abad, P; Herranz, LM; Jiménez, M; Prieto, MD; Suárez, C, 2012) |
| "To evaluate the effects of the transdermal electromotive administration of verapamil and dexamethasone on plaque size, penile deviation, pain, erectile function and capacity for vaginal penetration in patients with Peyronie's disease." | 3.72 | Transdermal electromotive administration of verapamil and dexamethasone for Peyronie's disease. ( Capelli, G; Di Stasi, SM; Giannantoni, A; Jannini, EA; Storti, L; Vespasiani, G; Virgili, G, 2003) |
| "Peyronie's disease is a condition that results in the development of penile plaques that can lead to penile curvature, pain, and erectile dysfunction, making sexual activity difficult." | 3.01 | Non-surgical therapies for Peyronie's disease. ( Blair, Y; Dahm, P; Edwards, ME; Ergun, O; Hwang, EC; Jung, JH; Risk, MC; Rosenberg, JE, 2023) |
| "Peyronie's disease is still a therapeutic dilemma for the urologist." | 2.77 | Pharmacological therapy in patients diagnosed with Peyronie's disease. ( Ceban, E; Geavlete, P; Halal, AA, 2012) |
| "Verapamil or saline was injected directly into the Peyronie's plaque once a week for 6 months." | 2.69 | Use of intralesional verapamil to dissolve Peyronie's disease plaque: a long-term single-blind study. ( Benet, A; Melman, A; Rehman, J, 1998) |
| "Medical treatment of Peyronie's disease (PD) in terms of intralesional therapy is still a matter of debate." | 2.61 | Comparative Effectiveness of Intralesional Therapy for Peyronie's Disease in Controlled Clinical Studies: A Systematic Review and Network Meta-Analysis. ( Albersen, M; Cacciamani, G; Cocci, A; Kessler, TM; Morgia, G; Russo, GI; Serefoglu, EC; Verze, P, 2019) |
| "Peyronie's disease is a collagen wound healing disorder of the penis that negatively affects the quality of life of afflicted men." | 2.53 | Peyronie's Disease: Intralesional Therapy and Surgical Intervention. ( Aliperti, LA; Mehta, A, 2016) |
| "Nonsurgical treatment of Peyronie's disease clearly has a place in the armamentarium of the practicing urologist." | 2.42 | Review of current nonsurgical management of Peyronie's disease. ( Levine, LA, 2003) |
| "Peyronie's disease has no known cause; recent understanding of the molecular mechanisms involved and the development of an animal model will aid the medical management of early disease." | 2.42 | The management of Peyronie's disease. ( Minhas, S; Ralph, DJ, 2004) |
| "Verapamil was detected in 71." | 1.32 | Tunica albuginea tissue analysis after electromotive drug administration. ( Cole, A; Estrada, CR; Levine, LA; Shou, W, 2003) |
| "Peyronie's disease is the most frequent cause of penile curvature and occurs particularly in middle-age patients." | 1.31 | A new biopsy technique to investigate Peyronie's disease associated histologic alterations: results with two different forms of therapy. ( Fusco, F; Imbimbo, C; Longo, N; Mirone, V; Palmieri, A; Tajana, G, 2002) |
| "No verapamil was detected in any tunical specimens." | 1.31 | Transdermal application of verapamil gel to the penile shaft fails to infiltrate the tunica albuginea. ( Badwan, K; Martin, DJ; Mulhall, JP; Parker, M, 2002) |
| "Peyronie's disease is a fibromatosis of the tunica albuginea which affects up to 2% of men." | 1.31 | Inhibition of Peyronie's plaque fibroblast proliferation by biologic agents. ( Anderson, MS; Lubrano, T; Mulhall, JP; Shankey, TV, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 9 (13.24) | 18.2507 |
| 2000's | 27 (39.71) | 29.6817 |
| 2010's | 27 (39.71) | 24.3611 |
| 2020's | 5 (7.35) | 2.80 |
| Authors | Studies |
|---|---|
| Chung, E | 2 |
| Wang, J | 1 |
| Levine, LA | 14 |
| Rosenberg, JE | 1 |
| Ergun, O | 1 |
| Hwang, EC | 1 |
| Risk, MC | 1 |
| Jung, JH | 1 |
| Edwards, ME | 1 |
| Blair, Y | 1 |
| Dahm, P | 1 |
| Sadagopan, A | 1 |
| Karaszewski, J | 1 |
| Zareba, I | 1 |
| Guszczyn, T | 1 |
| Darewicz, B | 1 |
| Palka, J | 1 |
| Asali, M | 2 |
| Favilla, V | 2 |
| Russo, GI | 3 |
| Zucchi, A | 1 |
| Siracusa, G | 1 |
| Privitera, S | 2 |
| Cimino, S | 2 |
| Madonia, M | 2 |
| Cai, T | 1 |
| Cavallini, G | 6 |
| Liguori, G | 1 |
| D'Achille, G | 1 |
| Silvani, M | 1 |
| Franco, G | 1 |
| Verze, P | 2 |
| Palmieri, A | 3 |
| Torrisi, B | 1 |
| Mirone, V | 3 |
| Morgia, G | 3 |
| Cacciamani, G | 1 |
| Cocci, A | 1 |
| Kessler, TM | 1 |
| Serefoglu, EC | 1 |
| Albersen, M | 1 |
| Gallo, L | 1 |
| Sarnacchiaro, P | 1 |
| Castelli, T | 1 |
| La Vignera, S | 1 |
| Condorelli, R | 1 |
| Calogero, AE | 1 |
| Farina, FP | 1 |
| Paulis, G | 5 |
| Giorgio, GD | 1 |
| Quattrocchi, S | 1 |
| Brancato, T | 5 |
| Alvaro, R | 4 |
| Jordan, GH | 1 |
| Carson, CC | 1 |
| Lipshultz, LI | 1 |
| Tan, RB | 1 |
| Sangkum, P | 1 |
| Mitchell, GC | 1 |
| Hellstrom, WJ | 4 |
| Sherer, BA | 1 |
| Warrior, K | 1 |
| Alizadeh, M | 1 |
| Karimi, F | 1 |
| Fallah, MR | 1 |
| Wolff, B | 1 |
| Peyronnet, B | 1 |
| Cattarino, S | 1 |
| Mozer, P | 1 |
| Renard-Penna, R | 1 |
| Phé, V | 1 |
| Bitker, MO | 1 |
| Rouprêt, M | 1 |
| Aliperti, LA | 1 |
| Mehta, A | 1 |
| Tuygun, C | 1 |
| Ozok, UH | 1 |
| Gucuk, A | 1 |
| Bozkurt, IH | 1 |
| Imamoglu, MA | 1 |
| Beley, S | 1 |
| Shirazi, M | 1 |
| Haghpanah, AR | 1 |
| Badiee, M | 1 |
| Afrasiabi, MA | 1 |
| Haghpanah, S | 1 |
| Brock, G | 1 |
| Vardi, Y | 1 |
| Chen, J | 1 |
| Hatzimouratidis, K | 1 |
| Sohn, M | 1 |
| Cockerham, YR | 1 |
| Heidari, M | 1 |
| Nejadi, JR | 1 |
| Ghate, A | 1 |
| Delfan, B | 1 |
| Iran-Pour, E | 1 |
| Gur, S | 1 |
| Limin, M | 1 |
| Moskovic, DJ | 1 |
| Alex, B | 1 |
| Choi, JM | 1 |
| Nelson, CJ | 1 |
| Mulhall, JP | 6 |
| D'Ascenzo, R | 2 |
| Nupieri, P | 2 |
| De Giorgio, G | 2 |
| Orsolini, G | 2 |
| Abern, MR | 1 |
| Larsen, S | 1 |
| Halal, AA | 1 |
| Geavlete, P | 1 |
| Ceban, E | 1 |
| Costabile, RA | 1 |
| Garrido Abad, P | 1 |
| Coloma, A | 1 |
| Herranz, LM | 1 |
| Jiménez, M | 1 |
| Suárez, C | 1 |
| Prieto, MD | 1 |
| Formoso, T | 1 |
| Fernández Arjona, M | 1 |
| Garcia, F | 1 |
| Young, LD | 1 |
| Solomon, M | 1 |
| Brock, GB | 1 |
| Mehrsai, AR | 1 |
| Namdari, F | 1 |
| Salavati, A | 1 |
| Dehghani, S | 1 |
| Allameh, F | 1 |
| Pourmand, G | 1 |
| Stein, A | 1 |
| Dekel, Y | 1 |
| Goldman, KE | 1 |
| Greenfield, JM | 2 |
| Imbimbo, C | 2 |
| Longo, N | 1 |
| Fusco, F | 2 |
| Tajana, G | 1 |
| Martin, DJ | 1 |
| Badwan, K | 1 |
| Parker, M | 1 |
| Estrada, CR | 2 |
| Shou, W | 1 |
| Cole, A | 1 |
| Di Stasi, SM | 2 |
| Giannantoni, A | 2 |
| Capelli, G | 2 |
| Jannini, EA | 2 |
| Virgili, G | 1 |
| Storti, L | 1 |
| Vespasiani, G | 2 |
| Ralph, DJ | 1 |
| Minhas, S | 1 |
| Stephen, RL | 1 |
| Giurioli, A | 1 |
| Ohebshalom, M | 1 |
| Russell, S | 1 |
| Steers, W | 1 |
| McVary, KT | 1 |
| Akin-Olugbade, Y | 1 |
| Shah, SJ | 1 |
| Fitch, WP | 1 |
| Easterling, WJ | 1 |
| Talbert, RL | 1 |
| Bordovsky, MJ | 1 |
| Mosier, M | 1 |
| Modenini, F | 1 |
| Vitali, G | 2 |
| Bennett, NE | 1 |
| Guhring, P | 1 |
| Levine, L | 1 |
| Merrick, PF | 1 |
| Lee, RC | 1 |
| Arena, F | 1 |
| Peracchia, G | 1 |
| Di Stefano, C | 1 |
| Passari, A | 1 |
| Larosa, M | 1 |
| Cortellini, P | 1 |
| Treffiletti, S | 1 |
| Annoscia, S | 1 |
| Montefiore, F | 1 |
| Boccafoschi, C | 1 |
| Rehman, J | 1 |
| Benet, A | 1 |
| Melman, A | 1 |
| Lasser, A | 1 |
| Vandenberg, TL | 1 |
| Vincent, MJ | 1 |
| Mantovani, F | 1 |
| Patelli, E | 1 |
| Colombo, F | 1 |
| Riedl, CR | 1 |
| Plas, E | 1 |
| Engelhardt, P | 1 |
| Daha, K | 1 |
| Pflüger, H | 1 |
| Anderson, MS | 1 |
| Shankey, TV | 1 |
| Lubrano, T | 1 |
| Biagiotti, G | 1 |
| Koverech, A | 1 |
19 reviews available for verapamil and Cavernitis, Fibrous
| Article | Year |
|---|---|
Non-surgical therapies for Peyronie's disease.
Topics: Erectile Dysfunction; Humans; Male; Pain; Penile Induration; Quality of Life; Randomized Controlled | 2023 |
A snapshot of intralesional verapamil injection in the treatment of Peyronie's disease today.
Topics: Calcium Channel Blockers; Humans; Injections, Intralesional; Male; Penile Induration; Penis; Sexual | 2019 |
Intralesional injection of the calcium channel blocker Verapamil in Peyronie's disease: A critical review.
Topics: Calcium Channel Blockers; Humans; Injections, Intralesional; Male; Penile Induration; Treatment Outc | 2020 |
Comparative Effectiveness of Intralesional Therapy for Peyronie's Disease in Controlled Clinical Studies: A Systematic Review and Network Meta-Analysis.
Topics: Adult; Humans; Hyaluronic Acid; Injections, Intralesional; Interferon alpha-2; Male; Microbial Colla | 2019 |
Minimally invasive treatment of Peyronie's disease: evidence-based progress.
Topics: 4-Aminobenzoic Acid; Administration, Oral; Calcium Channel Blockers; Carnitine; Colchicine; Evidence | 2014 |
Update on medical management of Peyronie's disease.
Topics: 4-Aminobenzoic Acid; Administration, Topical; Adrenal Cortex Hormones; Disease Management; High-Ener | 2014 |
2013-2014 updates in Peyronie's disease management.
Topics: Humans; Male; Penile Induration; Practice Guidelines as Topic; Urologic Surgical Procedures, Male; V | 2014 |
Peyronie's Disease: Intralesional Therapy and Surgical Intervention.
Topics: Calcium Channel Blockers; Humans; Interferon alpha-2; Interferon-alpha; Male; Microbial Collagenase; | 2016 |
Current status and new developments in Peyronie's disease: medical, minimally invasive and surgical treatment options.
Topics: 4-Aminobenzoic Acid; Colchicine; Collagenases; Drug Administration Routes; Humans; Interferon-alpha; | 2011 |
Inflammatory mechanisms and oxidative stress in Peyronie's disease: therapeutic "rationale" and related emerging treatment strategies.
Topics: Animals; Colchicine; Humans; Inflammation; Male; Oxidative Stress; Penile Induration; Penis; Reactiv | 2012 |
[Review of Peyronie's disease].
Topics: Colchicine; Humans; Injections, Intralesional; Male; Penile Induration; Tamoxifen; Verapamil; Vitami | 2012 |
Intralesional verapamil for the treatment of Peyronie's disease: a review.
Topics: Calcium Channel Blockers; Disease Progression; Humans; Injections, Intralesional; Male; Penile Indur | 2002 |
Review of current nonsurgical management of Peyronie's disease.
Topics: Antioxidants; Calcium Channel Blockers; Colchicine; Collagenases; Drug Therapy, Combination; Humans; | 2003 |
The management of Peyronie's disease.
Topics: 4-Aminobenzoic Acid; Colchicine; Humans; Interferon alpha-2; Interferon-alpha; Lithotripsy; Male; Pe | 2004 |
Towards an evidence-based understanding of Peyronie's disease.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Carnitine; Evidence-Based Medicine; Fibroblasts; Huma | 2005 |
Transdermal and topical pharmacotherapy for male sexual dysfunction.
Topics: Administration, Cutaneous; Administration, Topical; Alprostadil; Androgens; Animals; Erectile Dysfun | 2005 |
Systematic evidence-based analysis of plaque injection therapy for Peyronie's disease.
Topics: Adrenal Cortex Hormones; Collagenases; Evidence-Based Medicine; Humans; Injections, Intralesional; I | 2007 |
The medical management of Peyronie's disease.
Topics: Adrenal Cortex Hormones; Disease Management; Drug Therapy, Combination; Humans; Male; Penile Indurat | 2007 |
Advances in the medical therapy of Peyronie's disease: a brief review.
Topics: Colchicine; Collagenases; Humans; Male; Penile Induration; Verapamil | 1998 |
23 trials available for verapamil and Cavernitis, Fibrous
| Article | Year |
|---|---|
Intralesional collagenase
Topics: Humans; Injections, Intralesional; Male; Microbial Collagenase; Patient Satisfaction; Penile Indurat | 2022 |
Evaluation of intralesional injection of hyaluronic acid compared with verapamil in Peyronie's disease: preliminary results from a prospective, double-blinded, randomized study.
Topics: Adult; Aged; Double-Blind Method; Humans; Hyaluronic Acid; Injections, Intralesional; Italy; Male; M | 2017 |
Combination of intralesional verapamil and oral antioxidants for Peyronie's disease: a prospective, randomised controlled study.
Topics: Adult; Aged; Antioxidants; Calcium Channel Blockers; Humans; Injections, Intralesional; Male; Middle | 2014 |
Long-term multimodal therapy (verapamil associated with propolis, blueberry, vitamin E and local diclofenac) on patients with Peyronie's disease (chronic inflammation of the tunica albuginea). Results of a controlled study.
Topics: Adult; Aged; Aged, 80 and over; Blueberry Plants; Case-Control Studies; Diclofenac; Humans; Inflamma | 2013 |
Evaluation of verapamil efficacy in Peyronie's disease comparing with pentoxifylline.
Topics: Adult; Aged; Drug Therapy, Combination; Erectile Dysfunction; Humans; Iran; Male; Middle Aged; Pain; | 2014 |
The effectiveness of transdermal electromotive administration with verapamil and dexamethasone in the treatment of Peyronie's disease.
Topics: Administration, Cutaneous; Adult; Aged; Anti-Inflammatory Agents; Calcium Channel Blockers; Dexameth | 2009 |
Effect of intralesional verapamil for treatment of Peyronie's disease: a randomized single-blind, placebo-controlled study.
Topics: Calcium Channel Blockers; Humans; Injections, Intralesional; Male; Middle Aged; Penile Induration; P | 2009 |
Evaluation of intralesional injection of verapamil in treatment of Peyronie's disease.
Topics: Adult; Aged; Humans; Male; Middle Aged; Penile Induration; Surveys and Questionnaires; Treatment Out | 2010 |
Combination of penile traction, intralesional verapamil, and oral therapies for Peyronie's disease.
Topics: Administration, Oral; Age Factors; Combined Modality Therapy; Humans; Injections, Intralesional; Mal | 2012 |
Pharmacological therapy in patients diagnosed with Peyronie's disease.
Topics: Adult; Aged; Colchicine; Drug Therapy, Combination; Humans; Male; Middle Aged; Penile Induration; Ve | 2012 |
Peironimev-Plus® in the treatment of chronic inflammation of tunica albuginea (Peyronie's disease). results of a controlled study.
Topics: 4-Aminobenzoic Acid; Adult; Aged; Anthocyanins; Antioxidants; Biological Therapy; Chronic Disease; D | 2013 |
Efficacy of vitamin E in the conservative treatment of Peyronie's disease: legend or reality? A controlled study of 70 cases.
Topics: Administration, Topical; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Blueberry Plants; Cal | 2013 |
Comparison of transdermal electromotive administration of verapamil and dexamethasone versus intra-lesional injection for Peyronie's disease.
Topics: Administration, Cutaneous; Analysis of Variance; Calcium Channel Blockers; Dexamethasone; Drug Thera | 2013 |
A prospective, randomized study using transdermal electromotive administration of verapamil and dexamethasone for Peyronie's disease.
Topics: Administration, Cutaneous; Calcium Channel Blockers; Dexamethasone; Electricity; Humans; Male; Middl | 2004 |
Verapamil versus saline in electromotive drug administration for Peyronie's disease: a double-blind, placebo controlled trial.
Topics: Double-Blind Method; Humans; Iontophoresis; Male; Middle Aged; Patient Satisfaction; Penile Erection | 2007 |
Topical verapamil HCl, topical trifluoperazine, and topical magnesium sulfate for the treatment of Peyronie's disease--a placebo-controlled pilot study.
Topics: Administration, Topical; Adult; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administ | 2007 |
Open preliminary randomized prospective clinical trial of efficacy and safety of three different verapamil dilutions for intraplaque therapy of Peyronie's disease.
Topics: Adult; Dose-Response Relationship, Drug; Drug Administration Schedule; Follow-Up Studies; Humans; In | 2007 |
Intralesional verapamil prevents the progression of Peyronie's disease.
Topics: Adult; Disease Progression; Follow-Up Studies; Humans; Injections, Intralesional; Male; Middle Aged; | 2007 |
Treatment of Peyronie's disease with intralesional verapamil injection.
Topics: Adult; Aged; Humans; Injections, Intralesional; Male; Middle Aged; Penile Induration; Prospective St | 1997 |
Use of intralesional verapamil to dissolve Peyronie's disease plaque: a long-term single-blind study.
Topics: Adult; Aged; Calcium Channel Blockers; Clinical Protocols; Humans; Injections, Intralesional; Male; | 1998 |
Our experience on the association of a new physical and medical therapy in patients suffering from induratio penis plastica.
Topics: Adult; Combined Modality Therapy; Erectile Dysfunction; High-Energy Shock Waves; Humans; Male; Middl | 1999 |
Iontophoresis for treatment of Peyronie's disease.
Topics: Adult; Aged; Anti-Inflammatory Agents; Dexamethasone; Humans; Iontophoresis; Lidocaine; Male; Middle | 2000 |
Oral propionyl-l-carnitine and intraplaque verapamil in the therapy of advanced and resistant Peyronie's disease.
Topics: Administration, Oral; Adult; Aged; Analysis of Variance; Anti-Inflammatory Agents, Non-Steroidal; Ca | 2002 |
26 other studies available for verapamil and Cavernitis, Fibrous
| Article | Year |
|---|---|
A Primer on the History of Intralesional Verapamil Injection for Peyronie's Disease.
Topics: Humans; Injections, Intralesional; Male; Penile Induration; Verapamil | 2023 |
Verapamil and collagenase differentially affect collagen metabolism in experimental model of Peyronie's disease.
Topics: Animals; Cell Line; Cell Movement; Cell Survival; Collagen; Dipeptidases; DNA; Fibroblasts; Humans; | 2020 |
Ten-year experience with multimodal treatment for acute phase Peyronie's disease: A real life clinical report.
Topics: Acute Disease; Administration, Oral; Arginine; Clinical Protocols; Combined Modality Therapy; Drug A | 2019 |
Intralesional Injections for Early Peyronie Disease: Standardized Assessment and Analysis of Predictive Factors for Treatment Response.
Topics: Dose-Response Relationship, Drug; Early Diagnosis; Humans; Injections, Intralesional; Male; Middle A | 2015 |
[La Peyronie disease, erectile dysfunction, kidney tumors]].
Topics: Adult; Age Factors; Anti-Inflammatory Agents; Biopsy; Erectile Dysfunction; Follow-Up Studies; Human | 2008 |
Clinical case: 45-year-old male with penile pain (CME).
Topics: Anthropometry; Cicatrix; Erectile Dysfunction; Humans; Male; Middle Aged; Penile Induration; Phospho | 2009 |
Is there a place for conservative treatment in Peyronie's disease?
Topics: Administration, Topical; Expert Testimony; Gels; Humans; Iontophoresis; Male; Penile Induration; Pen | 2009 |
Intralesional injection therapy for Peyronie's disease.
Topics: Anesthetics, Local; Angiogenesis Inhibitors; Humans; Injections, Intralesional; Interferon alpha-2; | 2009 |
Current approach to the man with acute phase Peyronie's disease--case presentation and discussion.
Topics: Adult; Arginine; Disease Progression; Dose-Response Relationship, Drug; Drug Therapy, Combination; H | 2011 |
Defining predictors of response to intralesional verapamil injection therapy for Peyronie's disease.
Topics: Age Factors; Forecasting; Humans; Injections, Intralesional; Male; Middle Aged; Penile Induration; R | 2011 |
Effectiveness of antioxidants (propolis, blueberry, vitamin E) associated with verapamil in the medical management of Peyronie's disease: a study of 151 cases.
Topics: Adult; Aged; Antioxidants; Blueberry Plants; Calcium Channel Blockers; Cyclooxygenase Inhibitors; Di | 2012 |
Is intralesional verapamil effective therapy for Peyronie's disease?
Topics: Humans; Injections, Intralesional; Male; Penile Induration; Verapamil | 2012 |
Transdermal iontophoresis with verapamil and dexamethasone in the acute phase of peyronie's disease. Our experience.
Topics: Administration, Cutaneous; Adult; Aged; Anti-Inflammatory Agents; Calcium Channel Blockers; Coitus; | 2012 |
A comparative study of the efficacy of intralesional verapamil versus normal saline injection in a novel Peyronie disease animal model: assessment of immunohistopathological changes and erectile function outcome.
Topics: Animals; Disease Models, Animal; Immunohistochemistry; Injections, Intralesional; Male; Penile Erect | 2013 |
Experience with intraplaque injection of verapamil for Peyronie's disease.
Topics: Adult; Aged; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Injections, Int | 2002 |
A new biopsy technique to investigate Peyronie's disease associated histologic alterations: results with two different forms of therapy.
Topics: Adult; Aged; Biopsy, Needle; Calcium Channel Blockers; Humans; Male; Middle Aged; Penile Induration; | 2002 |
Transdermal application of verapamil gel to the penile shaft fails to infiltrate the tunica albuginea.
Topics: Absorption; Administration, Cutaneous; Calcium Channel Blockers; Gels; Humans; Male; Penile Indurati | 2002 |
Tunica albuginea tissue analysis after electromotive drug administration.
Topics: Drug Administration Routes; Electricity; Epinephrine; Humans; Male; Penile Induration; Penis; Tissue | 2003 |
Transdermal electromotive administration of verapamil and dexamethasone for Peyronie's disease.
Topics: Administration, Cutaneous; Adult; Aged; Dexamethasone; Drug Combinations; Erectile Dysfunction; Huma | 2003 |
Comment on 'Topical verapamil HCL, topical trifluoroperazine, and topical magnesium sulfate for the treatment of Peyronie's disease--a placebo-controlled pilot study'.
Topics: Administration, Topical; Adult; Double-Blind Method; Humans; Magnesium Sulfate; Male; Penile Erectio | 2007 |
Intralesional verapamil injection for the treatment of Peyronie's disease.
Topics: Adult; Aged; Follow-Up Studies; Humans; Injections, Intralesional; Male; Middle Aged; Penile Indurat | 1994 |
[Clinical effects of verapamil in the treatment of Peyronie's disease].
Topics: Calcium Channel Blockers; Humans; Male; Penile Induration; Retrospective Studies; Verapamil | 1995 |
[Iontophoresis in the conservative treatment of Peyronie's disease: preliminary experience].
Topics: Anti-Inflammatory Agents; Dexamethasone; Evaluation Studies as Topic; Follow-Up Studies; Humans; Ion | 1997 |
Intraplaque verapamil injection for treatment of Peyronie's disease.
Topics: Adult; Calcium Channel Blockers; Follow-Up Studies; Humans; Injections; Male; Middle Aged; Pain Meas | 1998 |
[Correction of acquired penile curvatures].
Topics: Calcinosis; Fibrosis; Humans; Male; Penile Induration; Penile Prosthesis; Penis; Prosthesis Design; | 1998 |
Inhibition of Peyronie's plaque fibroblast proliferation by biologic agents.
Topics: Alprostadil; Antiviral Agents; Calcium Channel Blockers; Cell Separation; Cells, Cultured; Colchicin | 2000 |